Pharmaceutical Executive Editorial Staff

Sharif has over a decade of experience working in the healthcare field.

New managing director Trevor Pill has been passed the company's helm from founder Karen Winterhalter.

Leo Tarkovsky brings more than 25 years of proven experience scaling companies in the healthcare space.

Under its Commercial License Agreement with OBT, Genmab will obtain the exclusive right to develop and commercialize novel antibody therapeutics utilizing OBT's novel, first-in-class IO antibody.

Fast-growing specialty pharma selects Veeva CRM and Veeva Vault PromoMats to build a unified foundation for commercial excellence.

The companies have shown a commitment to enhancing greater equity for women.

Created in response to emerging consumer trends and behaviors, these innovations support efforts to bridge gaps between people and quality care.

Heim is an accomplished business leader with strong leadership experience, and an established reputation within Pharmaceutical, Medical Device and Health Technology markets.

Award-winning healthcare IT PR agency and care operations automation leaders partner to bring world-class operations to health systems.

Lasso and CMI Media Group are the first to successfully leverage IBM Watson's dynamic creative capabilities for healthcare marketing, driving media performance 40% above benchmark.

Award-winning healthcare IT marketing & PR agency to collaborate with leader in data and analytics software solutions and services.

Rohit Gupta is vice president of analytics strategy and transformation at Beghou Consulting - he works with biopharma leaders on all facets of drug commercialization, from market sizing strategies, to launch planning, to business analytics.

Rotz discusses a report he co-authored for PwC about how life sciences companies perform on the S&P 500.

Indu Navar, founder of Everything ALS, speaks with Pharm Exec about how she lost her husband to the disease and how she's trying to improve the way its diagnosed.

The integration of the "Amplion knowledgebase" and next-generation data architecture will immediately expand Science & Medicine Group's capabilities to deliver more comprehensive, actionable insights to commercial organizations at life science equipment and reagent manufacturers as well as pharmaceutical services providers.

Latest innovation solves pharma brands' and agencies' long-standing need for transparent, data-driven DTC audience creation and campaign planning.

The fast-growing global naming and branding firm hired Switzerland-based Dan Hunt as managing director, Europe.

Barnes discusses alternative reimbursement plans for expensive, one-off therapies.

The $20 million, five-year-initiative will work to increase equity in U.S. cancer care.

Jones is credited with improving diversity at the organization.

Adam Carter discusses the causes and potential solutions to the pharma industry's sustainability issues.

Pharm Exec chats with Bridget Seay of epocrates about the non-personal promotion landscape as face-to-face contact with physicians dwindles.

Ryan Olohan, formerly Google Healthcare Managing Director, joins celebrated global health commercialization partner as Executive Vice President, Growth.

The report details the company's efforts environmental, social, and governance areas.

The new office will give clients access to the company's services in the Chinese market.

Hogan Lovells released a survey that tracked the thinking of compliance professionals who are implementing ESG into compliance programs.

Companies headquartered in the state raised the fourth highest annual total in the first half of this year.

The multi-regional agreement aims to commercialize Odevixibat in Canada and Israel, for the treatment of patients with cholestatic liver diseases.

Sam Ingram and Hui Tang reinforce the agency's commitment to digital experience and data & analytics.